Dec 9, 2024 07:33AM
May 28, 2024 08:00AM
May 20, 2024 12:00PM
Mar 19, 2024 08:30AM
Feb 22, 2024 04:00PM
Sep 27, 2023 08:30AM
Sep 26, 2023 08:30AM Cantex and Allegheny Health Network Announce Initiation of a Phase 1/2 Study of Azeliragon in Patients Refractory to First-Line Treatment of Metastatic Pancreatic Cancer
Sep 18, 2023 08:30AM
Aug 28, 2023 01:46PM
Aug 28, 2023 01:30PM
Aug 10, 2023 08:33AM
Jun 16, 2023 08:03AM
Jun 16, 2023 08:00AM
Jun 15, 2023 07:33AM CANTEX PHARMACEUTICALS TO PRESENT AT THE MEDINVEST ONCOLOGY INVESTOR CONFERENCE IN BOSTON
Jun 1, 2023 10:37AM
May 24, 2023 09:03AM
May 24, 2023 09:00AM
Mar 6, 2023 08:03AM
Mar 6, 2023 08:02AM
Feb 27, 2023 08:03AM
Feb 27, 2023 08:02AM Cantex Receives FDA "Study May Proceed" Letter for Phase 2 Clinical Trial of Azeliragon for the Treatment of Unmethylated Glioblastoma
Jan 9, 2023 08:00AM
Nov 24, 2020 05:09PM
Mar 20, 2019 09:13AM
Mar 1, 2016 07:00AM
Feb 22, 2016 07:07AM
Feb 22, 2016 07:00AM
Feb 9, 2016 04:05PM vTv Therapeutics Completes Enrollment of Phase 2b Trial Evaluating TTP399 for the Treatment of Type 2 Diabetes
Jan 21, 2016 07:08AM
Jan 21, 2016 07:00AM
Nov 12, 2015 04:05PM

66,407 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All